InsidersTradesSigma
Follow the SYN2BIO S.A. share price and the full insider trade history of the company, a listed equity based in Poland. Shares are listed on the PL market, under the authority of KNF. Operating in the Health Care sector, SYN2BIO S.A. has recorded 6 insider filings. Market capitalisation: €555.2m. The latest transaction was disclosed on 9 September 2026 (Purchase). Among the most active insiders: Maciej Zarębiński. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
SYN2BIO S.A. 是一家专注于健康和制药行业的公司。该公司在 XWAR 市场上市。